MercyOne Genesis Silvis Medical Center
801 Illini Drive, Silvis, IL · MercyOne · · NPI 1427132604
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Injection, siltuximab HCPCS J2860 | $9,427.67 | $15,712.78 | $168.83 – $3,449.73 | 5 |
| Injection(s) tendon sheath/ligament aponeurosis single (both sides) CPT 20550 | $348.00 | $580.00 | $170.20 – $2,143.62 | 5 |
| Injection(s) trigger point(s) single/multiple 1 or 2 muscle(s) CPT 20552 | $363.60 | $606.00 | $159.16 – $493.89 | 5 |
| Injection(s) trigger point(s) single/multiple >= 3 muscle(s) CPT 20553 | $436.20 | $727.00 | $181.24 – $592.51 | 5 |
| Injection therapeutic/prophylactic/diagnostic each addl sequential IV push same substance/drug CPT 96376 | $106.80 | $178.00 | $50.82 – $359.12 | 4 |
| Injection, ticarcillin disod HCPCS S0040 | not published | not published | $1,223.58 – $1,223.58 | 1 |
| Injection torsemide 10 mg/ml HCPCS J3265 | $26.06 | $43.43 | $13.90 – $37.78 | 4 |
| Injection treatment of eye CPT 66020 | not published | not published | $1,038.71 – $3,566.22 | 3 |
| Injection treatment of eye CPT 66030 | not published | not published | $1,038.71 – $3,566.22 | 3 |
| Injection treatment of nerve CPT 64605 | not published | not published | $1,443.96 – $3,053.41 | 3 |
| Injection treatment of nerve CPT 64610 | not published | not published | $1,443.96 – $3,053.41 | 3 |
| Injection treatment of nerve CPT 64681 | not published | not published | $928.06 – $1,392.08 | 3 |
| Injection treatment of nose CPT 30200 | not published | not published | $182.30 – $796.28 | 3 |
| Inject sacroiliac joint CPT 27096 | $1,168.20 | $1,947.00 | $415.04 – $2,143.62 | 4 |
| Inject/treat eye socket CPT 67500 | not published | not published | $289.02 – $467.42 | 3 |
| Inject/treat eye socket CPT 67505 | not published | not published | $289.02 – $467.42 | 3 |
| Inject/treat eye socket CPT 67515 | not published | not published | $289.02 – $467.42 | 3 |
| Inj, eculizumab-aagh, 2 mg HCPCS Q5151 | not published | not published | $32.68 – $49.02 | 3 |
| Inj, eculizumab-aeeb, 2 mg HCPCS Q5152 | not published | not published | $43.25 – $64.88 | 3 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | $28,508.30 | $47,513.83 | $35.17 – $41,337.03 | 5 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $22.02 – $33.02 | 3 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $397.83 – $596.74 | 3 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $59.87 – $89.80 | 3 |
| Inj epidural sgl cerv-thor without img CPT 62320 | $190.80 | $318.00 | $292.56 – $750.77 | 2 |
| Inj epidural sgl lumb-sacral without img CPT 62322 | $164.40 | $274.00 | $252.08 – $750.77 | 2 |
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $104.99 – $104.99 | 1 |
| Inj, erzofri, 1 mg HCPCS J2428 | not published | not published | $17.88 – $26.82 | 3 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $104.99 – $104.99 | 1 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $16,423.08 – $16,423.08 | 1 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $197.80 – $296.70 | 3 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $18.11 – $27.16 | 3 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,430,923.44 – $3,646,385.16 | 3 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $10.33 – $15.50 | 3 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $35.94 – $53.91 | 3 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $19.75 – $29.63 | 3 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $146.39 – $219.58 | 3 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.26 – $1.89 | 3 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $7.75 – $11.62 | 3 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.99 – $4.49 | 3 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $104.99 – $104.99 | 1 |
| Inj for ext venography CPT 36005 | $660.00 | $1,100.00 | $95.68 – $2,143.62 | 4 |
| Inj for mammo ductogram CPT 19030 | $462.00 | $770.00 | $156.16 – $2,143.62 | 4 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $1.18 – $1.77 | 3 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $187.98 – $948.11 | 3 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $187.98 – $187.98 | 1 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $3.46 – $5.19 | 3 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $48.17 – $72.26 | 3 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $118.14 – $118.14 | 1 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $110.67 – $110.67 | 1 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $122.16 – $183.24 | 3 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,888.10 – $4,332.15 | 3 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $1.93 – $2.89 | 3 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $16,423.08 – $16,423.08 | 1 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.17 – $7.76 | 3 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $78.04 – $117.05 | 3 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $4,230.73 – $4,230.73 | 1 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $23,609.42 – $5,762,393.52 | 3 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | $18.40 | $30.66 | $9.81 – $26.67 | 4 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | $8,322.19 | $13,870.31 | $65.64 – $12,067.17 | 5 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $80.78 – $121.17 | 3 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $3,183.60 | $5,306.00 | $340.32 – $2,143.62 | 4 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $658.80 | $1,098.00 | $340.32 – $2,143.62 | 4 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | $664.20 | $1,107.00 | $340.32 – $2,143.62 | 4 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $823.80 | $1,373.00 | $340.32 – $2,143.62 | 4 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $184.80 | $308.00 | $98.56 – $2,143.62 | 4 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.58 – $2.38 | 3 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | $1,797.27 | $2,995.45 | $5.40 – $1,710.90 | 5 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | $1,271.73 | $2,119.55 | $104.99 – $1,844.01 | 4 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $82.76 – $124.14 | 3 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $9.30 – $13.95 | 3 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.72 – $4.08 | 3 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $493.92 – $493.92 | 1 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.14 – $0.20 | 3 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $515.40 – $773.11 | 3 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | $561.60 | $936.00 | $750.77 – $861.12 | 2 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $116.23 – $116.23 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $154.80 | $258.00 | $82.56 – $2,143.62 | 5 |
| Inj intralesional > 7 lsns CPT 11901 | $134.40 | $224.00 | $171.71 – $206.08 | 2 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $13.51 – $20.26 | 3 |
| Inj ivig privigen 500 mg HCPCS J1459 | $13,368.87 | $22,281.45 | $52.57 – $2,460.67 | 5 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.99 – $2.99 | 3 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.76 – $4.14 | 3 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.65 – $2.47 | 3 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $16,423.08 – $16,423.08 | 1 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | $15,763.10 | $26,271.83 | $25.49 – $22,856.49 | 5 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | $1,174.88 | $1,958.14 | $1.39 – $707.19 | 5 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $118.14 – $118.14 | 1 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.95 – $34.43 | 3 |
| Inj levocarnitine per 1 gm HCPCS J1955 | $65.56 | $109.26 | $34.96 – $95.06 | 4 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $43.11 – $43.11 | 1 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $7.40 – $11.10 | 3 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $5.36 – $8.04 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,399,701.68 – $5,099,552.52 | 3 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $343.06 – $514.59 | 3 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $24.38 – $36.57 | 3 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,297.33 – $4,946.00 | 3 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $52.86 – $79.29 | 3 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | $2,951.66 | $4,919.43 | $112.61 – $4,243.90 | 5 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $67.53 – $101.29 | 3 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $7,497.06 – $7,497.06 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.